Compound Description
| ID: C0355 | Common name: Quetiapine |
| IUPAC: 2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol | CAS: CAS:111974-69-7 |
| Chembl ID: CHEMBL716 | Pubchem ID: CID:5002 |
| Formula: C21H25N3O2S | TCM-ID: TCMC1989 |
| Smiles: OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 | |
| Alias:
2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol;
Dibenzo[b,f][1,4]thiazepine, ethanol deriv.; Ketipinor; Quetiapine; Seronia |
Structure:
|
Related Targets (Total: 5)
| Target id | Protein Name | Gene Symbol | Uniprot ID | Target Level | No.of Literature Evidence |
|---|---|---|---|---|---|
| T48ZIG | D(2) dopamine receptor | DRD2 |
P14416 |
A | 2 Reference(s) |
| T30D9G | Superoxide dismutase [Cu-Zn] | SOD1 |
P00441 |
A | 1 Reference(s) |
| T71BDH | Mitogen-activated protein kinase 14 | MAPK14 |
Q16539 |
C | 1 Reference(s) |
| T77W8L | Ribosomal protein S6 kinase alpha-1 | RPS6KA1 |
Q15418 |
C | 1 Reference(s) |
| T63GUB | Proto-oncogene c-Fos | FOS |
P01100 |
C | 1 Reference(s) |
*In this table, target level represents the quality confidence indicators of targets.
Level 'A' represents "Directly inhibit/activate".
Level 'B' represents "Indirectly inhibit/ activate", "Enzyme substate" and "Enzyme product".
Level 'C' represents "Up/Down regulation" and "Others".
Level 'A' represents "Directly inhibit/activate".
Level 'B' represents "Indirectly inhibit/ activate", "Enzyme substate" and "Enzyme product".
Level 'C' represents "Up/Down regulation" and "Others".
Related Herbs (Total: 2)
Ckey description of the interaction between compound and target